Activation Capital Unveils Plans for New Innovative Life Sciences Center at Bio+Tech Park in Richmond

Activation Capital Unveils Plans for New Innovative Life Sciences Center at Bio+Tech Park in Richmond

This article is part of our Capital Projects section, sponsored by ECBuild / EwingCole. Discover the latest real estate projects making an impact in the regions that we serve and learn more about the companies building them. Have a project that you want to share with our community? Get in touch!

By Chris Frew
June 6, 2023

Richmond, Virginia, is set to witness a remarkable new development that will further enhance their life sciences ecosystem with Activation Capital’s announcement of the upcoming Innovation Center at Bio+Tech Park. Spanning an impressive 102,000 square feet, this state-of-the-art facility aims to foster innovation, drive economic growth, and become a thriving hub for the life sciences industry. With a strategic vision and support from the community, Activation Capital aims to revolutionize downtown Richmond and create opportunities for the region’s entrepreneurs and researchers.

Located in downtown Richmond, adjacent to the renowned VCU Medical Center, the 34-acre Bio+Tech Park has already established itself as a premier commercial life sciences hub. Currently housing over 70 companies, research institutes, and state/federal laboratories, the park provides a conducive environment for collaboration and breakthrough discoveries. Activation Capital’s investment in the Innovation Center is set to further bolster the region’s life sciences ecosystem.

Here’s what you need to know about the new project:

Innovation Center Features:

The Innovation Center will be a cutting-edge facility, planned for completion in late 2025. With approximately 35,000 square feet of high-quality lab and creative office space, it aims to attract a lead tenant to anchor the center. Additionally, the center will dedicate around 45,000 square feet to an incubator, operated by Activation Capital. This incubator will provide shared labs, private offices, and community gathering spaces, fostering a collaborative and supportive environment for startups and early-stage companies. The building will be situated at the corner of 8th Street and Jackson Street, acting as a beacon of progress in the heart of downtown Richmond.

Catalyzing Economic Growth:

Activation Capital’s strategic plan revolves around creating a thriving ecosystem that generates wealth-creating jobs and strengthens the region’s end-to-end pharmaceutical manufacturing cluster. By establishing the Innovation Center as a magnet for innovators and entrepreneurs, Activation Capital aims to boost entrepreneurial growth in Richmond and foster a culture of deep tech innovation. The center will not only attract talented individuals but also serve as a platform for STEM programming, enabling community members to enhance their skills and contribute to the region’s technological advancements.

Collaborative Leasing Representation:

To ensure the success of the Innovation Center, Activation Capital has partnered with esteemed commercial real estate firm, Cushman & Wakefield | Thalhimer. With their deep expertise in both commercial real estate and life sciences, they will provide exclusive leasing representation for the center. This collaboration signifies Activation Capital’s commitment to agility, collaboration, and future-focus, as well as their dedication to creating a renowned life science innovation center that benefits generations to come.

Activation Capital’s announcement of the Innovation Center at Bio+Tech Park marks an exciting milestone for the Richmond life sciences community. This development will not only drive economic growth but also position Richmond as a prominent player in the global life sciences industry. With its cutting-edge facilities, collaborative environment, and focus on innovation, the Innovation Center is set to become a hub for groundbreaking research, entrepreneurial endeavors, and the growth of deep tech companies. Activation Capital’s vision, in partnership with Cushman & Wakefield | Thalhimer, will shape the future of life sciences in Richmond, attracting top talent and propelling the region’s scientific advancements to new heights.

For more information and updates, visit www.activation.capital.

Discover the latest projects making an impact in the region and the companies building them. 
Click below…

Latest

Nathan Roman Named Market Activator for Greater Philadelphia at BioBuzz

Life sciences validation expert to lead ecosystem engagement and...

A Neuro Hub in the Making: Baltimore’s Ecosystem Begins to Coalesce at 4MLK

Baltimore’s life sciences ecosystem is entering a more defined...

BioBuzz and Heffron Company Announce Strategic Partnership to Support Life Sciences Community and Workforce Growth

The three-year collaboration highlights a shared commitment to strengthening...

Newsletter

spot_img

Don't miss

Nathan Roman Named Market Activator for Greater Philadelphia at BioBuzz

Life sciences validation expert to lead ecosystem engagement and...

A Neuro Hub in the Making: Baltimore’s Ecosystem Begins to Coalesce at 4MLK

Baltimore’s life sciences ecosystem is entering a more defined...

BioBuzz and Heffron Company Announce Strategic Partnership to Support Life Sciences Community and Workforce Growth

The three-year collaboration highlights a shared commitment to strengthening...

Katie Sillex Joins NEU-ION as Business Development Leader

Positioned to drive new business, strengthen partnerships, and support...
spot_imgspot_img

Nathan Roman Named Market Activator for Greater Philadelphia at BioBuzz

Life sciences validation expert to lead ecosystem engagement and programming across the Greater Philadelphia region. BioBuzz has appointed Nathan Roman as Market Activator for the...

A Neuro Hub in the Making: Baltimore’s Ecosystem Begins to Coalesce at 4MLK

Baltimore’s life sciences ecosystem is entering a more defined phase—one where the conversation is shifting from individual breakthroughs to how the broader system comes...

OneCyte and Kemp Proteins Announce Strategic Partnership to Accelerate High-Performance Cell Line Development for Next-Generation Biologics

Photo Credit: OneCyte and Kemp Proteins collaboration OneCyte, a leader in high-throughput single-cell analysis and cell line development technologies, and Kemp Proteins, a pioneer in...

Leave a Reply

Discover more from News

Subscribe now to keep reading and get access to the full archive.

Continue reading